窥得儿医药（QuidelOrtho）今日盘中股价大涨10.87%，引起投资者广泛关注。这一显著涨幅主要源于公司最新发布的季度财报超出市场预期。
根据公司公布的截至3月31日的季度业绩报告，窥得儿医药调整后每股收益达0.74美元，不仅大幅高于去年同期的0.44美元，更是超过了分析师平均预期的0.59美元。尽管季度营收同比小幅下降2.6%至6.93亿美元，但仍高于市场预期的6.90亿美元。这份亮眼的财报无疑提振了投资者信心。
值得注意的是，窥得儿医药股价在过去一个季度曾下跌25.8%，今年以来更是累计下跌41.8%。然而，分析师对公司前景仍保持乐观态度，目前对该股的平均评级为"买入"，12个月目标价中位数为54美元。摩根大通也将该公司的目标价从25美元上调至27美元，进一步反映了市场对窥得儿医药长期发展前景的信心。这次超预期的季度业绩或将成为公司股价触底反弹的重要契机。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.